Annual Conference

Now Open! Call for Abstracts for the General Poster Session

NCCN welcomes original abstracts from investigators in general oncology community. Submissions will be accepted from academic institutions, teaching and community hospitals, or industry. Participants from both NCCN and non-NCCN Member Institutions may submit abstracts.

The NCCN General Poster Session, including submission review, is overseen by the NCCN Oncology Research Program (ORP). The submission deadline is Wednesday, October 30, 2024, 11:59 PM ET. Corresponding authors can expect to receive notification via e-mail in mid-December 2024.

Submit Abstract

Registration Now Open!

New location! Caribe Royale Orlando · Orlando, FL | Virtual attendance also available
Friday, March 28 – Sunday, March 30, 2025

Register by March 3 for the best rates!

Learn More

Join Us in Orlando or Virtually!

NCCN 2025 Annual Conference Agenda

View Now

Save the Dates

NCCN 2025 Nursing Program: Advancing Oncology Nursing™
Thursday, March 27, 2025
New location! Caribe Royale Orlando, Orlando, FL

NCCN 2026 Annual Conference
Friday, March 27 – Sunday, March 29, 2026
Caribe Royale Orlando, Orlando, FL

Continuing Education

The NCCN 2024 Annual Conference included educational sessions highlighting significant updates and key issues for select NCCN Guidelines^®, new and emerging therapies, controversies in oncology care, issues affecting oncology care, and strategies to address barriers to practice. This educational program was designed to meet the educational needs of physicians/oncologists, nurse practitioners, nurses, PAs, pharmacists, and other health care professionals who manage patients with cancer.

CE credit is available for the oncology team. Explore 35 recorded educational sessions!

Record presentations from the 2024 NCCN Annual Conference are now available on NCCN Continuing Education Portal.

View Now

2024 Annual Conference Supporters

This activity is supported by educational grants from:

AstraZeneca
Coherus BioSciences
Dendreon Pharmaceuticals LLC.
Eisai
Exact Sciences
Genentech, a member of the Roche Group
GRAIL, LLC
GSK
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Lilly
Menarini-Stemline
Novartis
Novocure
Olympus Corporation of the Americas
Sanofi
Sirtex
Taiho Oncology, Inc.

Supported by a grant from:

Pfizer Inc.

This project has been made possible in part by a grant from:

Varian Medical Systems, a Siemens Healthineers company /Global Medical Education Grant Program

Supported by independent educational grants from:

Daiichi Sankyo
Incyte Corporation
Merck & Co., Inc., Rahway, NJ, USA

Supported by independent medical education grants from:

Boehringer Ingelheim Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.

Supported by a medical education grant from:

Karyopharm Therapeutics

Exhibit Hall

Visit the NCCN Exhibition Hall in-person or virtually for networking opportunities and to gather the latest information from industry-sponsored exhibits and more.

View Exhibitor Prospectus

For exhibitor opportunities, contact exhibits@nccn.org.